[PDF] cell.comFull View

[PDF][PDF] Shared GABA transmission pathology in dopamine agonist-and antagonist-induced dyskinesia

Y Abe, S Yagishita, H Sano, Y Sugiura, M Dantsuji… - Cell Reports …, 2023 - cell.com
Dyskinesia is involuntary movement caused by long-term medication with dopamine-related
agents: the dopamine agonist 3, 4-dihydroxy-L-phenylalanine (L-DOPA) to treat Parkinson's …
被引用次数：4 相关文章

Shared GABA transmission pathology in dopamine agonist-and antagonist-induced dyskinesia

Y Abe, S Yagishita, H Sano, Y Sugiura… - Cell reports …, 2023 - pubmed.ncbi.nlm.nih.gov
Dyskinesia is involuntary movement caused by long-term medication with dopamine-related
agents: the dopamine agonist 3, 4-dihydroxy-L-phenylalanine (L-DOPA) to treat Parkinson's …
[PDF] researchgate.net

[PDF][PDF] Shared GABA transmission pathology in dopamine agonist-and antagonist-induced dyskinesia

Y Abe, S Yagishita, H Sano, Y Sugiura, M Dantsuji… - Cell …, 2023 - researchgate.net
Dyskinesia is involuntary movement caused by long-term medication with dopamine-related
agents: the dopamine agonist 3, 4-dihydroxy-L-phenylalanine (L-DOPA) to treat Parkinson's …

Shared GABA transmission pathology in dopamine agonist-and antagonist-induced dyskinesia

Y Abe, S Yagishita, H Sano, Y Sugiura… - Cell Reports …, 2023 - pure.fujita-hu.ac.jp
抄録 Dyskinesia is involuntary movement caused by long-term medication with dopamine-
related agents: the dopamine agonist 3, 4-dihydroxy-L-phenylalanine (L-DOPA) to treat …
[HTML] sciencedirect.com

[HTML][HTML] Shared GABA transmission pathology in dopamine agonist-and antagonist-induced dyskinesia

Y Abe, S Yagishita, H Sano, Y Sugiura, M Dantsuji… - Cell Reports …, 2023 - Elsevier
Dyskinesia is involuntary movement caused by long-term medication with dopamine-related
agents: the dopamine agonist 3, 4-dihydroxy-L-phenylalanine (L-DOPA) to treat Parkinson's …

Shared GABA transmission pathology in dopamine agonist-and antagonist-induced dyskinesia.

Y Abe, S Yagishita, H Sano, Y Sugiura… - Cell reports …, 2023 - europepmc.org
Dyskinesia is involuntary movement caused by long-term medication with dopamine-related
agents: the dopamine agonist 3, 4-dihydroxy-L-phenylalanine (L-DOPA) to treat Parkinson's …
[HTML] nih.gov

[HTML][HTML] Shared GABA transmission pathology in dopamine agonist-and antagonist-induced dyskinesia

Y Abe, S Yagishita, H Sano, Y Sugiura… - Cell Reports …, 2023 - ncbi.nlm.nih.gov
Dyskinesia is involuntary movement caused by long-term medication with dopamine-related
agents: the dopamine agonist 3, 4-dihydroxy-L-phenylalanine (L-DOPA) to treat Parkinson's …

Shared GABA transmission pathology in dopamine agonist-and antagonist-induced dyskinesia

Y Abe, S Yagishita, H Sano, Y Sugiura, M Dantsuji… - bioRxiv, 2023 - biorxiv.org
Dyskinesia is involuntary movement caused by long-term medication with dopamine-related
agents: the dopamine agonist, L-DOPA, to treat Parkinson disease (L-DOPA-induced …

Shared GABA transmission pathology in dopamine agonist-and antagonist-induced dyskinesia

Y Abe, S Yagishita, H Sano, Y Sugiura… - Cell Reports …, 2023 - keio.elsevierpure.com
抄録 Dyskinesia is involuntary movement caused by long-term medication with dopamine-
related agents: the dopamine agonist 3, 4-dihydroxy-L-phenylalanine (L-DOPA) to treat …

Shared GABA transmission pathology in dopamine agonist-and antagonist-induced dyskinesia.

Y Abe, S Yagishita, H Sano, Y Sugiura… - Cell reports …, 2023 - europepmc.org
Dyskinesia is involuntary movement caused by long-term medication with dopamine-related
agents: the dopamine agonist 3, 4-dihydroxy-L-phenylalanine (L-DOPA) to treat Parkinson's …